Guotai SSE Science And Technology Innovation Board Innovative Drugs ETF (589720) Latest Quoted at RMB 0.86, SSE Science and Technology Innovation Board Innovative Drugs Index (950161) Up 3.53%

NewTimeSpace (newtimespace.com) News, as of 14:54 on September 14, 2026, the SSE Science and Technology Innovation Board Innovative Drugs Index (950161) surged 3.53%, with the Guotai SSE Science And Technology Innovation Board Innovative Drugs ETF (589720) last quoted at RMB 0.86.

In terms of fund flows, the Guotai SSE Science And Technology Innovation Board Innovative Drugs ETF recorded a latest net fund outflow of RMB 20.6621 million. Over a longer horizon, it saw net fund inflows on 3 of the past 5 trading days, totaling RMB 202 million in "fund attraction", with an average daily net inflow of RMB 40.3736 million. (Source: Wind)

Data shows that leveraged funds continue to build positions. The Guotai SSE Science And Technology Innovation Board Innovative Drugs ETF has a latest margin purchase amount of RMB 36.9273 million and a latest margin balance of RMB 434 million. (Source: Wind)

In terms of return capability, as of September 11, 2026, since its inception, the ETF's highest single-month return was 5.48%, its longest winning streak was 2 months, its longest rally gain was 6.23%, and its average return rate in rising months was 3.73%. As of September 11, 2026, the ETF's annualized excess return over the benchmark over the past 3 months was 3.13%.

In terms of drawdown, as of September 11, 2026, the ETF's drawdown relative to the benchmark over the past six months was 0.15%, the smallest drawdown among comparable funds. The number of days to recovery after the drawdown was 25 days.

In terms of fees, the ETF's management fee rate is 0.50% and its custody fee rate is 0.10%, the lowest fee rates among comparable funds.

In terms of tracking precision, as of September 11, 2026, the ETF's tracking error over the past month was 0.032%, the highest tracking precision among comparable funds.

In terms of valuation, the SSE Science and Technology Innovation Board Innovative Drugs Index tracked by the Guotai SSE Science And Technology Innovation Board Innovative Drugs ETF (589720) has a latest price-to-earnings ratio (PE-TTM) of only 74.77x, at the 0.57% percentile over the past year, meaning its valuation is below that of over 99.43% of the time over the past year, placing it at a historic low.

The Guotai SSE Science And Technology Innovation Board Innovative Drugs ETF (589720) closely tracks the SSE Science and Technology Innovation Board Innovative Drugs Index. The SSE Science and Technology Innovation Board Innovative Drugs Index selects the securities of no more than 30 listed companies in the innovative drugs field from the Science and Technology Innovation Board as its index samples, so as to reflect the overall performance of the securities of innovative drug listed companies on the Science and Technology Innovation Board.

NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.